← Evidence map

ArticleCancers2023

Thiazolidinedione Use Is Associated with a Borderline Lower Risk of Multiple Myeloma and a Significantly Lower Risk of Death in Patients with Type 2 Diabetes Mellitus in Taiwan.

Chin-Hsiao TsengPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023

2024

this papercites it

Thiazolidinedione Use Is Associated with a Borderline Lower Risk of Multiple Myeloma and a Significantly Lower Risk of Death in Patients with Type 2 Diabetes Mellitus in Taiwan. | Socratic